Apeloa Pharmaceutical Co.,Ltd (SHE:000739)
China flag China · Delayed Price · Currency is CNY
18.11
+0.41 (2.32%)
Apr 8, 2026, 3:04 PM CST

SHE:000739 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
9,72811,95711,44010,5068,910
Other Revenue
55.4865.3533.9239.132.44
9,78412,02211,47410,5458,943
Revenue Growth (YoY)
-18.62%4.77%8.81%17.92%13.49%
Cost of Revenue
7,2989,2258,6218,0756,579
Gross Profit
2,4862,7962,8532,4702,364
Selling, General & Admin
971.421,1211,125985.33906.43
Research & Development
611.17641.47624.87532.92446.22
Other Operating Expenses
35.3812.7623.331.7633.05
Operating Expenses
1,6081,7851,7751,5631,405
Operating Income
877.831,0121,078906.8959.39
Interest Expense
-24.65-32.2-43.77-59.23-35.72
Interest & Investment Income
131.7892.17113.4775.83165.7
Currency Exchange Gain (Loss)
-25.5158.3838.1393.42-23.09
Other Non Operating Income (Expenses)
-1.822.18-23.85-5.38-3.58
EBT Excluding Unusual Items
957.621,1321,1621,0111,063
Gain (Loss) on Sale of Investments
--10.13-21.7-82.61-23.62
Gain (Loss) on Sale of Assets
9.030.281.331.370.28
Asset Writedown
-5-8.37--4.67-7.95
Other Unusual Items
104.5589.2263.2386.5282.67
Pretax Income
1,0661,2031,2051,0121,114
Income Tax Expense
175.52172.44149.3422.89158.53
Earnings From Continuing Operations
890.681,0311,055989.17955.55
Minority Interest in Earnings
-00.270.030-
Net Income
890.681,0311,055989.17955.55
Net Income to Common
890.681,0311,055989.17955.55
Net Income Growth
-13.62%-2.30%6.69%3.52%17.00%
Shares Outstanding (Basic)
1,1531,1631,1691,1741,179
Shares Outstanding (Diluted)
1,1531,1631,1691,1741,179
Shares Change (YoY)
-0.86%-0.52%-0.40%-0.38%-0.00%
EPS (Basic)
0.770.890.900.840.81
EPS (Diluted)
0.770.890.900.840.81
EPS Growth
-12.87%-1.78%7.12%3.91%17.00%
Free Cash Flow
833.99748.01400.9817-90.18
Free Cash Flow Per Share
0.720.640.340.70-0.08
Dividend Per Share
0.5860.3560.3170.2970.285
Dividend Growth
64.68%12.35%6.70%4.21%17.28%
Gross Margin
25.41%23.26%24.86%23.42%26.43%
Operating Margin
8.97%8.42%9.39%8.60%10.73%
Profit Margin
9.10%8.58%9.20%9.38%10.69%
Free Cash Flow Margin
8.52%6.22%3.49%7.75%-1.01%
EBITDA
1,5401,5761,6311,2961,318
EBITDA Margin
15.74%13.11%14.21%12.29%14.74%
D&A For EBITDA
662.17564.15553.06389.43358.64
EBIT
877.831,0121,078906.8959.39
EBIT Margin
8.97%8.42%9.39%8.60%10.73%
Effective Tax Rate
16.46%14.33%12.40%2.26%14.23%
Revenue as Reported
9,78412,02211,47410,5458,943
Advertising Expenses
9.3511.299.671.611.86
Source: S&P Global Market Intelligence. Standard template. Financial Sources.